ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65 | -66.5% | 18,023 | -69.2% | 0.00% | -50.0% |
| Q1 2023 | $194 | +71.7% | 58,507 | +100.5% | 0.00% | +100.0% |
| Q4 2022 | $113 | -100.0% | 29,180 | -79.5% | 0.00% | -75.0% |
| Q3 2022 | $346,000 | +276.1% | 142,471 | +206.9% | 0.00% | +300.0% |
| Q2 2022 | $92,000 | +178.8% | 46,423 | +144.7% | 0.00% | – |
| Q1 2021 | $33,000 | -26.7% | 18,968 | -18.3% | 0.00% | – |
| Q4 2020 | $45,000 | -87.0% | 23,210 | -80.4% | 0.00% | -100.0% |
| Q2 2020 | $346,000 | -4.4% | 118,200 | -6.0% | 0.00% | 0.0% |
| Q1 2020 | $362,000 | – | 125,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |